Cargando…

Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination

BACKGROUND: Obstetric fistula (OF) is a significant cause of maternal morbidity in lower resource settings where women experience obstructed labor without timely access to skilled obstetric care. The true prevalence of OF is unknown; however, it is estimated to affect 2 to 3.5 million women globally...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chi Chiung Grace, Long, Annelise, Rwabizi, Denis, Mbabazi, Gerard, Ndizeye, Ntwali, Dushimiyimana, Blaise, Ngoga, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764794/
https://www.ncbi.nlm.nih.gov/pubmed/35042512
http://dx.doi.org/10.1186/s12978-021-01317-2
_version_ 1784634236487073792
author Chen, Chi Chiung Grace
Long, Annelise
Rwabizi, Denis
Mbabazi, Gerard
Ndizeye, Ntwali
Dushimiyimana, Blaise
Ngoga, Eugene
author_facet Chen, Chi Chiung Grace
Long, Annelise
Rwabizi, Denis
Mbabazi, Gerard
Ndizeye, Ntwali
Dushimiyimana, Blaise
Ngoga, Eugene
author_sort Chen, Chi Chiung Grace
collection PubMed
description BACKGROUND: Obstetric fistula (OF) is a significant cause of maternal morbidity in lower resource settings where women experience obstructed labor without timely access to skilled obstetric care. The true prevalence of OF is unknown; however, it is estimated to affect 2 to 3.5 million women globally. The Demographic and Health Surveys’ (DHS) Fistula Module includes the OF symptom questions most frequently used for prevalence estimates, but these questions have not been validated. The aim of this study is to validate a symptom-based screening questionnaire for OF, including a question in the DHS’ Fistula Module. METHODS: With an international panel of fistula surgeons, we developed and face-validated a screening questionnaire that assessed for symptoms of lower urinary tract fistula (LUTF) and lower gastrointestinal tract fistula (LGTF), as well as urinary and fecal incontinence (UI, FI). We evaluated the discriminative ability of the questionnaire using a case–control study design in a 1:2:2 ratio: cases were parous women with fistula confirmed on examination, controls included parous women without fistula on examination, with and without UI symptoms. All women underwent screening for fistula symptoms and a physical examination, with examiners blinded to screening results. RESULTS: Of the 367 Rwandan women who completed the questionnaires and underwent clinical examination, 59 women had LUTFs and 34 had LGTFs, 274 women were classified as controls with and without symptoms of UI. All LUTF screening questions performed well, including the DHS fistula question. The combination of two LUTF screening questions had the highest sensitivity (100%; 95% CI 94%, 100%), specificity (96%; 95% CI 93%, 98%), and area under the curve (AUC) (0.98). The combination of a LGTF screening question and FI question demonstrated the highest sensitivity (97%; 95% CI 85%, 100%), specificity (98%; 95% CI 95%, 99%) and AUC (0.98). CONCLUSIONS: Our OF screening questionnaire, including the DHS fistula question, demonstrated high sensitivities, specificities, and AUC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12978-021-01317-2.
format Online
Article
Text
id pubmed-8764794
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87647942022-01-18 Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination Chen, Chi Chiung Grace Long, Annelise Rwabizi, Denis Mbabazi, Gerard Ndizeye, Ntwali Dushimiyimana, Blaise Ngoga, Eugene Reprod Health Research BACKGROUND: Obstetric fistula (OF) is a significant cause of maternal morbidity in lower resource settings where women experience obstructed labor without timely access to skilled obstetric care. The true prevalence of OF is unknown; however, it is estimated to affect 2 to 3.5 million women globally. The Demographic and Health Surveys’ (DHS) Fistula Module includes the OF symptom questions most frequently used for prevalence estimates, but these questions have not been validated. The aim of this study is to validate a symptom-based screening questionnaire for OF, including a question in the DHS’ Fistula Module. METHODS: With an international panel of fistula surgeons, we developed and face-validated a screening questionnaire that assessed for symptoms of lower urinary tract fistula (LUTF) and lower gastrointestinal tract fistula (LGTF), as well as urinary and fecal incontinence (UI, FI). We evaluated the discriminative ability of the questionnaire using a case–control study design in a 1:2:2 ratio: cases were parous women with fistula confirmed on examination, controls included parous women without fistula on examination, with and without UI symptoms. All women underwent screening for fistula symptoms and a physical examination, with examiners blinded to screening results. RESULTS: Of the 367 Rwandan women who completed the questionnaires and underwent clinical examination, 59 women had LUTFs and 34 had LGTFs, 274 women were classified as controls with and without symptoms of UI. All LUTF screening questions performed well, including the DHS fistula question. The combination of two LUTF screening questions had the highest sensitivity (100%; 95% CI 94%, 100%), specificity (96%; 95% CI 93%, 98%), and area under the curve (AUC) (0.98). The combination of a LGTF screening question and FI question demonstrated the highest sensitivity (97%; 95% CI 85%, 100%), specificity (98%; 95% CI 95%, 99%) and AUC (0.98). CONCLUSIONS: Our OF screening questionnaire, including the DHS fistula question, demonstrated high sensitivities, specificities, and AUC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12978-021-01317-2. BioMed Central 2022-01-18 /pmc/articles/PMC8764794/ /pubmed/35042512 http://dx.doi.org/10.1186/s12978-021-01317-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Chi Chiung Grace
Long, Annelise
Rwabizi, Denis
Mbabazi, Gerard
Ndizeye, Ntwali
Dushimiyimana, Blaise
Ngoga, Eugene
Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination
title Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination
title_full Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination
title_fullStr Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination
title_full_unstemmed Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination
title_short Validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination
title_sort validation of an obstetric fistula screening questionnaire: a case–control study with clinical examination
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764794/
https://www.ncbi.nlm.nih.gov/pubmed/35042512
http://dx.doi.org/10.1186/s12978-021-01317-2
work_keys_str_mv AT chenchichiunggrace validationofanobstetricfistulascreeningquestionnaireacasecontrolstudywithclinicalexamination
AT longannelise validationofanobstetricfistulascreeningquestionnaireacasecontrolstudywithclinicalexamination
AT rwabizidenis validationofanobstetricfistulascreeningquestionnaireacasecontrolstudywithclinicalexamination
AT mbabazigerard validationofanobstetricfistulascreeningquestionnaireacasecontrolstudywithclinicalexamination
AT ndizeyentwali validationofanobstetricfistulascreeningquestionnaireacasecontrolstudywithclinicalexamination
AT dushimiyimanablaise validationofanobstetricfistulascreeningquestionnaireacasecontrolstudywithclinicalexamination
AT ngogaeugene validationofanobstetricfistulascreeningquestionnaireacasecontrolstudywithclinicalexamination